Germany is the third-largest drug market in the world – and the biggest in Europe – but its cost-containment measures in recent years have seen some pharma companies opt out of launching medici
Paul Tunnah spoke to Jane Griffiths, company group chairman, Janssen pharma companies (Johnson & Johnson) EMEA, at the recent eyeforpharma Barcelona event about some of the big questions fa
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
